12 November, 2018 (London) – Scius Communications was pleased to once again support EBD Group’s Bio-Europe’s Startup Slam, taking place in Copenhagen. Eight life sciences startups pitched at this popular session, sponsored and co-hosted by Johnson & Johnson Innovation for the fifth time running. SunRegen Healthcare was announced as this years winner, developing a potentially transformative solution for neurodegenerative eye diseases, and received a complimentary registration to BIO-Europe Spring® 2019 in Vienna, plus access to a top-tier mentoring program with industry experts from Johnson & Johnson Innovation.
This year’s line-up of innovative startups included digital health, therapeutics, and diagnostics companies, developing novel therapeutics for the potential treatment of diabetes, neurological and ophthalmic diseases, as well as diagnostics for cancer and mental health. The finalists were selected from over 60 applications, the largest number received by the Startup Slam to date.
Contestants had three minutes each to present their company and innovation to a panel of experienced investors and potential collaboration partners. The expert judging panel consisted of Guenter Huhle, Head of Johnson & Johnson Innovation – JLABS, EMEA*; Ingrid Teigland Akay, Managing Partner, Hadean Ventures; Claus Andersson, Partner, Sunstone Life Science Ventures; Dr. Stefan Luzi, Partner, Glide Healthcare; and Anna Gran*, New Venture Lead, Johnson & Johnson Innovation, Nordics. Scius hosted a webinar ahead of the event to prepare companies ahead of their investor pitches and supported media outreach, gaining coverage of the event.
Katja Stout, Managing Director of Scius Communications, said; ‘Its always a pleasure to work with EBD Group, the Johnson & Johnson Innovation team, and the contestants around this high energy and fun event. The EBD group pioneered the StartUp slam format, a great way to showcase early science and innovation from across the globe with potential partners and investors.”
See link to full press release: